Directorate Change

GlaxoSmithKline PLC 21 January 2005 Issued - Friday 21st January 2005, London - LSE Announcement GLAXOSMITHKLINE PLC ANNOUNCES A CHANGE TO THE AUDIT COMMITTEE AUDIT COMMITTEE The Board has appointed Sir Deryck Maughan a member of the Audit Committee, with immediate effect. A table showing the membership of the Board and its committees with effect from 21st January 2005 is attached to this announcement. S M Bicknell Company Secretary 21st January 2005 BOARD AND COMMITTEE MEMBERSHIP WITH EFFECT FROM 21ST JANUARY 2005. Sir Christopher Gent Chairman Sir Ian Prosser Senior Independent Non-Executive Director Dr J-P Garnier Chief Executive Officer Mr J D Coombe Chief Financial Officer Dr Tachi Yamada Executive Director, Chairman, Research & Development Mr H Lawrence Culp Independent Non-Executive Director Sir Crispin Davis Independent Non-Executive Director Sir Deryck Maughan Independent Non-Executive Director Dr Ronaldo Schmitz Independent Non-Executive Director Dr Lucy Shapiro Non-Executive Director Sir Robert Wilson Independent Non-Executive Director Board Committee Committee Chairman Members Audit Dr Ronaldo Schmitz Sir Deryck Maughan Sir Ian Prosser Sir Robert Wilson Remuneration Sir Robert Wilson Mr H Lawrence Culp Jnr. Sir Crispin Davis Nominations Sir Christopher Gent Sir Ian Prosser Dr Ronaldo Schmitz Corporate Responsibility Sir Christopher Gent Sir Ian Prosser Dr Lucy Shapiro This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings